You just read:

SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma

News provided by

SFJ Pharma

09 Jan, 2012, 09:05 GMT